Lonza Group Ltd (LONN) reported 1.2 times the Scope 1 and 2 emissions of Lupin Limited (LUPIN.NS) in 2025
Each figure is the company’s latest reported year, linked to its filing. Figures as of November 2026.
Scope 1 and 2 are the greenhouse gases from a company’s own operations and the energy it buys; Scope 3 is everything else in its value chain. All figures are in tonnes of CO₂ equivalent (tCO₂e). Industry is the company’s sector on the SBTi registry, the Science Based Targets initiative that checks corporate climate targets.
Scope 1 and 2 emissions
- AbbVie Inc. (ABBV) reports more Scope 1 and 2 emissions than 60 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
- Lupin Limited (LUPIN.NS) reports more Scope 1 and 2 emissions than 57 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
- Lonza Group Ltd (LONN) reports more Scope 1 and 2 emissions than 61 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
These are absolute footprints, so they measure a company’s size as much as its efficiency. A large company can be efficient and still sit near the top.
tCO₂e, latest reported year for each company
- AbbVie Inc. (ABBV)380,850 tCO₂e, 2025
- Lupin Limited (LUPIN.NS)332,149 tCO₂e, 2025
- Lonza Group Ltd (LONN)410,000 tCO₂e, 2025
- Pharmaceuticals and biotechnology median94,489 tCO₂e
Scope 3 emissions
- Scope 3 is 75% of Lupin Limited (LUPIN.NS)’s total reported footprint.
- Scope 3 is 85% of Lonza Group Ltd (LONN)’s total reported footprint.
tCO₂e, latest reported year for each company
- AbbVie Inc. (ABBV)Not reported
- Lupin Limited (LUPIN.NS)1,018,683 tCO₂e, 2025
- Lonza Group Ltd (LONN)2,303,000 tCO₂e, 2025
Change over time
The SBTi cross-sector pathway for 1.5°C asks for about 4.2% less each year. A change needs two reported years at most three years apart, the latest from 2023 or later.
Average change a year, compound, between the two latest reported years
- AbbVie Inc. (ABBV)down 9.8% a year2024 to 2025
- Lupin Limited (LUPIN.NS)up 2.1% a year2024 to 2025
- Lonza Group Ltd (LONN)down 10.1% a year2024 to 2025
- SBTi 1.5°C referencedown 4.2% a year
Climate targets
AbbVie Inc. (ABBV)
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2030
- Net-zero target
- None
Lupin Limited (LUPIN.NS)
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2033
- Net-zero target
- None
Lonza Group Ltd (LONN)
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2030
- Net-zero target
- None
Carbon credit retirements
Tonnes of CO₂e retired, where the company is the named beneficiary
- AbbVie Inc. (ABBV)None found
- Lupin Limited (LUPIN.NS)None found
- Lonza Group Ltd (LONN)2 t
Retirements come from public registries (CarbonPlan and VROD) and cover November 2024 onward, matched to companies by name, so a missing figure does not mean a company never retired credits.
Sources
AbbVie Inc. (ABBV)
Lupin Limited (LUPIN.NS)
Lonza Group Ltd (LONN)
How the comparison works
- Each company’s figures are its latest reported year in the emissions registry, from its own filings. A gap means the company has not reported that figure; it is never filled in or estimated.
- A zero or implausibly large figure (Scope 1 and 2 above 100 million tCO₂e, or Scope 3 above 1 billion) is shown with a “figure under review” tag and never ranked.
- The industry position compares a company’s latest Scope 1 and 2 figure from 2023 or later with every other company in the same SBTi industry that has one. It is shown only when at least 10 companies report.
- Profiles Carbon3 prepared ahead of a claim are shown here but left out of industry statistics.
Need a deeper peer review for your company?
Contact us